FDA Inspection 1324094 — Immunex Rhode Island Corporation

Immunex Rhode Island Corporation — FEI 3003359885

The FDA completed an inspection of Immunex Rhode Island Corporation on June 3, 2026 in West Greenwich, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 3, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Greenwich, RI (United States)